The reductive activation of the antitumor drug RH1 to its semiquinone free radical by NADPH cytochrome P450 reductase and by HCT116 human colon cancer cells

By Hasinoff Brian B.   begleiter Asher  

Free Radical Research, Vol. 40, Iss. 9, 2006-09 ,pp. : 974-978

Informa Healthcare

Access to resources Recommend Favorite

Difluoro analogue of UCS15A triggers activation of exogenously expressed c-Src in HCT 116 human colorectal carcinoma cells

By Atatreh Noor   Barraclough Jane   Welman Arkadiusz   Cawthorne Christopher   Bryce Richard   Dive Caroline   Freeman Sally  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 22, Iss. 5, 2007-10 ,pp. : 638-646

Informa Healthcare

Access to resources Recommend Favorite

CacyBP/SIP phosphatase activity in neuroblastoma NB2a and colon cancer HCT116 cells

By Kilanczyk Ewa   Wasik Urszula   Filipek Anna  

Biochemistry and Cell Biology, Vol. 90, Iss. 4, 2012-08 ,pp. : 558-564

NRC Research Press

Access to resources Recommend Favorite

Suppression of mitochondrial NADP⁺⁺-dependent isocitrate dehydrogenase activity enhances curcumin-induced apoptosis in HCT116 cells

By Jung Kyu Ho   Park Jeen-Woo  

Free Radical Research, Vol. 45, Iss. 4, 2011-04 ,pp. : 431-438

Informa Healthcare

Access to resources Recommend Favorite

LYG-202 inhibits the proliferation of human colorectal carcinoma HCT-116 cells through induction of G1/S cell cycle arrest and apoptosis via p53 and p21^WAF1/Cip1 expression

By Liu Wei   Dai Qinsheng   Lu Na   Wei Libin   Ha Jun   Rong Jingjing   Mu Rong   You Qidong   Li Zhiyu   Guo Qinglong  

Biochemistry and Cell Biology, Vol. 89, Iss. 3, 2011-06 ,pp. : 287-298

NRC Research Press

Access to resources Recommend Favorite